Apollo Hospitals Enterprise cash flow

Latest FY26

Cash from operations: ₹2,856cr+33.7% on FY25
Capital spending: ₹1,962cr+14.6% on FY25
Free cash flow: ₹894cr+110.9% on FY25
Cash from financing: −₹478cr₹1,317 cr in FY25

₹ crore except per share

Tap a line for its trend	Last 12Mto Jun 2026	FY26Mar 2026	FY25Mar 2025	FY24Mar 2024	FY23Mar 2023	FY22 and earlierAlpha Plus

Changes in working capital
Adjustments to reconcile profit — non-cash items						FY22 and earlierEvery year the company has filed comes with Alpha Plus.
	—	876	758	687	615
	—	0.0	2.0	0.0	0.0
	—	450	459	449	381
	—	−74.0	−92.4	−42.9	−44.4
	—	−2.7	−0.7	0.0	0.0
	—	−62.1	−63.4	−30.3	−12.8
	—	159	113	87.5	76.0
	—	−0.2	0.1	0.1	−0.3
	—	0.0	62.9	71.8	−3.1
	—	−14.8	−6.9	−5.4	−0.7
	—	88.7	0.0	0.0	54.3
	—	−61.1	−21.0	−69.2	41.9
	—	−553	−564	−335	−522
	—	0.0	0.0	−16.0	−103
	—	−177	5.2	−221	−66.2
	—	21.4	0.0	−22.6	−101
	—	0.0	−14.5	23.3	−32.7
	—	8.6	−128	411	281
	—	136	0.0	614	−20.8
	—	0.0	43.8	−606	10.1
	—	39.9	0.0	−2.1	42.5
	—	0.0	26.4	−1.9	0.6
	—	—	48.4	33.2	19.1
	—	12.1	46.0	33.2	19.1
Cash from operating activities
	2,832	2,616	2,006	1,363	1,144
	—	845	624	1,025	615
	—	3,461	2,630	2,387	1,759
	—	606	494	467	382
	—	2,856	2,136	1,920	1,377
Cash from investing activities
	—	1,962	1,713	1,137	1,129
	—	31.1	14.9	1.9	4.1
	—	0.0	0.0	1,171	0.0
	—	0.0	0.0	817	0.0
	—	6.9	3,218	0.0	992
	—	0.3	1,815	0.0	1,213
	—	1,300	0.0	3.7	49.9
	—	12.5	29.1	14.0	4.9
	—	26.8	8.4	16.5	3.0
	—	11.8	9.8	0.0	5.0
	—	84.3	84.4	39.3	44.2
	—	979	−354	−85.9	49.3
	—	−2,148	−3,381	−1,537	−857
Cash from financing activities
	—	0.0	45.9	2.4	0.0
	—	2.6	0.0	0.0	0.0
	—	0.0	0.0	0.0	4.5
	—	0.0	2.4	14.4	0.0
	—	1,115	2,551	707	585
	—	734	442	254	516
	—	291	256	0.0	197
	—	—	—	229	0.0
	—	278	302	303	251
	—	293	278	221	258
	—	0.0	1.0	0.0	0.0
	—	−478	1,317	−311	−633
	—	230	72.6	72.0	−113
	—	230	72.6	72.0	−113
	—	—	578	72.0	433
Reference items
	4,010	3,769	3,022	2,391	2,050
	15.2%	14.9%	13.9%	12.5%	12.3%
	894	894	424	784	249
	—	999	2,235	932	—
	₹62.15	₹62.15	₹29.46	₹54.49	₹17.28
	130.93×	—	—	—	—
	—	1.43×	1.42×	2.05×	1.63×
	—	606	494	467	382
	—	278	302	303	251

Open the chart

From the company's filings with NSE and BSE (Ind-AS), consolidated. For information only, not investment advice.

alphave

APOLLOHOSP₹8,137.00

Apollo Hospitals Enterprise Ltd.

· Pharma & Health

₹ CrorePeersFORTIS MAXHEALTH MEDANTA SUNPHARMA CIPLA DRREDDY DIVISLAB TORNTPHARMMcap ₹1.17L Cr

View

In ₹ Crore except Per Share 12 Months Ending	FY23 31/03/2023	FY24 31/03/2024	FY25 31/03/2025	FY26 31/03/2026	Last 12M 30/06/2026
Adjustments to Reconcile Profit — Non-cash Items
+ Depreciation & Amortisation	615.2	687.0	757.5	876.1	—
+ Impairment Loss / (Reversal)	0.0	0.0	2.0	0.0	—
+ Finance Costs	380.8	449.4	458.5	449.6	—
+ Interest Income	-44.4	-42.9	-92.4	-74.0	—
+ Dividend Income	0.0	0.0	-0.7	-2.7	—
+ Fair Value (Gains) / Losses	-12.8	-30.3	-63.4	-62.1	—
+ Share-based Payments	76.0	87.5	112.7	158.9	—
+ Unrealised FX (Gain) / Loss	-0.3	0.1	0.1	-0.2	—
+ Other Non-cash Items	-3.1	71.8	62.9	0.0	—
+ Other — Cash Effects are Investing / Financing	-0.7	-5.4	-6.9	-14.8	—
+ Other Reconciling Items	54.3	0.0	0.0	88.7	—
Changes in Working Capital
+ Inventories	41.9	-69.2	-21.0	-61.1	—
+ Trade Receivables — Current	-521.8	-335.2	-564.2	-553.3	—
+ Other Financial Assets — Current	-103.1	-16.0	0.0	0.0	—
+ Other Financial Assets — Non-current	-66.2	-221.2	5.2	-177.3	—
+ Other Current Assets	-100.5	-22.6	0.0	21.4	—
+ Other Non-current Assets	-32.7	23.3	-14.5	0.0	—
+ Trade Payables — Current	280.9	410.8	-128.0	8.6	—
+ Other Financial Liabilities — Current	-20.8	614.0	0.0	135.6	—
+ Other Financial Liabilities — Non-current	10.1	-605.8	43.8	0.0	—
+ Other Current Liabilities	42.5	-2.1	0.0	39.9	—
+ Other Non-current Liabilities	0.6	-1.9	26.4	0.0	—
+ Provisions	19.1	33.2	48.4	—	—
+ Provisions — Current	19.1	33.2	46.0	12.1	—
Cash from Operating Activities
Profit Before Tax (per I/S)	1,143.9	1,362.5	2,006.1	2,616.0	2,832.3
+ Total Adjustments (incl. Working Capital)	615.1	1,024.5	624.0	845.4	—
Cash from Operations (pre-tax)	1,759.0	2,387.0	2,630.1	3,461.4	—
+ Income Taxes Paid	382.0	466.7	493.7	605.7	—
Cash from Operating Activities	1,377.1	1,920.3	2,136.4	2,855.7	—
Cash from Investing Activities
+ Acq of Fixed Assets (Capex)	1,128.5	1,136.8	1,712.7	1,962.0	—
+ Disp of Fixed Assets	4.1	1.9	14.9	31.1	—
+ Acq of Other Long-term Assets	0.0	1,171.1	0.0	0.0	—
+ Disp of Other Long-term Assets	0.0	816.7	0.0	0.0	—
+ Purchase of Investments (Equity / Debt)	991.9	0.0	3,217.6	6.9	—
+ Sale of Investments (Equity / Debt)	1,212.8	0.0	1,815.1	0.3	—
+ Acq of Subsidiaries / Businesses (net)	49.9	3.7	0.0	1,300.3	—
+ Loans & Advances Made	4.9	14.0	29.1	12.5	—
+ Loans & Advances Repaid	3.0	16.5	8.4	26.8	—
+ Dividends Received — Investing	5.0	0.0	9.8	11.8	—
+ Interest Received — Investing	44.2	39.3	84.4	84.3	—
+ Other Inflows / (Outflows) — Investing	49.3	-85.9	-353.8	979.2	—
Cash from Investing Activities	-856.9	-1,537.1	-3,380.6	-2,148.2	—
Cash from Financing Activities
+ Proceeds from Issue of Shares	0.0	2.4	45.9	0.0	—
+ Proceeds from Other Equity Instruments	0.0	0.0	0.0	2.6	—
+ Proceeds — Change in Ownership of Subsidiaries	4.5	0.0	0.0	0.0	—
+ Payments — Change in Ownership of Subsidiaries	0.0	14.4	2.4	0.0	—
+ Proceeds from Borrowings	584.9	707.4	2,551.1	1,114.9	—
+ Repayment of Borrowings	516.1	253.9	442.2	734.0	—
+ Payment of Lease Liabilities	197.3	0.0	256.3	290.7	—
+ Payment of Finance Lease Liabilities	0.0	228.9	—	—	—
+ Interest Paid	251.4	302.9	301.9	277.6	—
+ Dividends Paid	257.9	220.9	278.4	292.8	—
+ Other Inflows / (Outflows) — Financing	0.0	0.0	1.0	0.0	—
Cash from Financing Activities	-633.3	-311.2	1,316.8	-477.6	—
Net Changes in Cash (pre-FX)	-113.1	72.0	72.6	229.9	—
Net Changes in Cash	-113.1	72.0	72.6	229.9	—
Closing Cash	433.4	72.0	578.1	—	—
Reference Items
EBITDA	2,049.6	2,390.7	3,021.8	3,769.3	4,009.5
EBITDA Margin %	12.34	12.54	13.87	14.94	15.17
Free Cash Flow (CFO − Capex)	248.5	783.5	423.7	893.7	893.7
Free Cash Flow to Equity	—	932.2	2,235.1	999.4	—
Free Cash Flow per Basic Share	17.28	54.49	29.46	62.15	62.15
Price to Free Cash Flow	—	—	—	—	130.93
Cash Flow to Net Income	1.63	2.05	1.42	1.43	—
Cash Paid for Taxes	382.0	466.7	493.7	605.7	—
Cash Paid for Interest	251.4	302.9	301.9	277.6	—

As filed, sign as filed: a payment tagged as a positive magnitude in the filing stays positive here, so read the label, not the sign. A line appears only when the company tagged that concept in at least one period shown — depth follows the filer, so a thin statement means a thin filing. Total Adjustments is the filer's own grand total of the reconciliation and spans BOTH the non-cash items and the working-capital block; Profit Before Tax plus it equals Cash from Operations (pre-tax). It can be reported when its components are not, so it is never a sum of the rows above it. No consensus estimates → no Est columns. Click any row to chart it.

« ‹ › »Latest: FY26 · ConsolidatedFA Financial Analysis · alphave

Data & compliance. Descriptive financial information from official NSE/BSE filings — for information and education only, not investment advice, a recommendation, or a valuation. Standalone = parent entity; consolidated includes subsidiaries. Historical multiples pair each fiscal year's filed figures with that FY-end market close; the Current column uses the last close with the latest filed annuals. Figures are cross-verified via accounting identities and NSE×BSE agreement — XBRL cross-verified ✓ 145%.